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Abstract
Purpose. To investigate the use of a corneal impression membrane (CIM) for the detection of herpes simplex virus type 1 
(HSV-1) in suspected herpes simplex keratitis (HSK).
Methodology. In the laboratory study, swabs and CIMs made from polytetrafluoroethylene were spiked with different concen-
trations of HSV-1. DNA was extracted and real-time PCR undertaken using two sets of primers. In the clinical study, consecutive 
patients presenting with suspected HSK were included. For each patient, samples were collected from corneal lesions with a 
swab and a CIM in random order. Clinical details were collected using a standardized clinical form and patients were catego-
rized into probable, presumed and possible HSK.
Results. There was no difference in the performance of both primer sets for all HSV-1 dilutions (P=0.83) using a CIM or between 
a CIM and a swab (P=0.18). In total, 110 patients were included. Overall, 73 patients (66.4 %) had probable, 20 patients (18.2 %) 
presumed and 17 patients (15.5 %) possible HSV-1 keratitis. The HSV-1 detection rate was significantly higher using a CIM 
(40/110, 36.4 %) than a swab (28/110, 25.5 %) (P=0.004). In the probable HSV keratitis group, the detection rate using a CIM was 
43.8 % compared to 27.4 % for a swab (P=0.004). The cycle threshold values obtained for the conjunctival swabs were higher 
than those obtained for the CIMs (P<0.001).
Conclusions. In suspected HSK, a CIM is a useful alternative to a swab and more likely to detect the presence of HSV-1.
InTRoduCTIon
Microbial keratitis due to herpes simplex virus type 1 (HSV-1) 
is a leading cause of visual impairment [1]. The annual inci-
dence of HSV-1 keratitis (HSK) in the United States and 
France has been estimated at 8.4 and 31.5 per 100 000 [2]. 
HSK most commonly presents as an epithelial keratitis with 
virus replicating in, and destroying, epithelial cells [3]. The 
lesions start as punctuate vesicular eruptions in the corneal 
epithelium, which coalesce into dendritiform lesions and 
occasionally into larger geographic lesions [4]. HSK is prone 
to recurrence, usually manifesting as a dendritiform keratitis 
and or an interstitial stromal keratitis.
Microbial keratitis, however, can be caused by a variety of 
micro-organisms. Although the clinical features of HSK 
can be characteristic, there are other diseases and infections 
with similar features. HSV-1 is also a consideration in many 
other types of infection of the cornea such as acanthamoeba 
keratitis. Misdiagnosis has been associated with significantly 
worse outcomes for the patient for example, confusing HSK 
and acanthamoebic keratitis [5]. In addition, there has been 
an increase in HSV-1 resistance to topical and systemic anti-
viral agents [6, 7]. It is important, therefore, to identify and 
if possible, isolate HSV-1 for clinical management. Isolation 
of HSV-1 by culture has a low sensitivity but is the standard 
for diagnostic specificity, potential strain identification and 
epidemiological tracing [8]. Although a variety of other 
laboratory tests on ocular surface samples have been used, 
some of these, such as cell cytology and viral antigen detec-
tion (immunoassays), have low specificity and sensitivity [9] 
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and have been replaced by viral DNA detection, in particular 
real-time PCR [8, 10, 11].
The collection of samples from corneal lesions in HSK is 
conventionally undertaken using a swab, or less commonly 
a blade or a needle to scrape the edges of the ulcer. Swabs, 
however, are cumbersome, may be difficult to localize to 
the ulcer using slit lamp biomicroscopy and, may come 
into contact with the conjunctiva and or the eyelids. This 
is important as asymptomatic shedding of HSV-1 into the 
tear film over the conjunctiva has been reported so that it 
is necessary to sample the corneal lesion itself [12, 13]. It is 
unclear, however, whether in clinical practice the majority of 
specimens are collected from the conjunctiva and tear film 
rather than from the cornea. Sharp instruments, such as a 
blade or needle, more commonly used in suspected bacterial 
or fungal ulcers, are seldom used for the detection of HSV-1, 
particularly because they require expertise and may lead to 
further corneal injury.
Corneal impression membranes (CIMs) made for example, 
from cellulose acetate or polytetrafluoroethylene (PTFE) 
have been used to collect samples from the cornea and or the 
conjunctiva. This method, called impression cytology (IC), 
has been shown to reliably remove epithelial surface cells 
from the ocular surface for diagnostic purposes in a variety 
of infectious and non-infectious corneal conditions, including 
viral [14], fungal [15], acanthamoeba [16] and bacterial kera-
titis [17], ocular surface neoplasia [18], keratoconjunctivitis 
sicca [19], vitamin A deficiency [20] and atopic keratocon-
junctitivits [21]. The removal of human epithelial cells using 
a CIM enables amplification of human DNA as an internal 
control and an indication of sample quality. In contrast, it is 
not known whether and to what extent a swab collects corneal 
epithelial cells, which is important for intracellular infections 
such as HSV-1. As has been shown in cases of suspected 
bacterial, acanthamoeba and fungal keratitis, use of a CIM 
has several practical advantages over conventional methods 
using swabs or sharp instruments, with good isolation rates 
[17]. This technique is easy to perform, less traumatic and 
invasive for the patient and if needed, can be sized to cover the 
entire ulcer [17]. In addition, it has recently been shown that 
HSV-1, acanthamoeba and pseudomonas aeruginosa DNA is 
stable for prolonged time periods on a CIM [22].
To date, however, there are no clinical data available on the 
comparison of detection rates for HSV-1 using the above 
mentioned collection techniques. In addition, a variety of 
different sets of PCR primers have been used for the detec-
tion of HSV-1 in cases of suspected HSK. Bennett et al. [8] 
demonstrated that the primers designed and used by Ryncarz 
et al. [10] on CSF, have good sensitivity and specificity when 
used in a multiplex PCR for the detection of HSV-1 from eye 
swabs. Dupuis primers have been shown to have good sensi-
tivity and specificity on CSF (Cerebrospinal fluid) samples 
and have also been used to demonstrate the stability of HSV-1 
DNA on a CIM [11, 22]. Comparison between primer sets is 
useful in cases where the result may be equivocal. The aim 
of this study, therefore, was to compare in vitro and in vivo, 
the detection of HSV-1 using a CIM and a swab and for the 
former, whether this was dependent on the set of primers 
used for the PCR. Two sets of primers were used to compare 
in vitro, spiked swabs and CIMs and then a clinical study was 




The performance of two HSV-1 primer sets in PCRs was eval-
uated, those from Ryncarz et al. [10] and Dupuis et al. [11]. 
PCRs for both primer sets comprised Roche Lightcycler 480 
Probes Master Mix (Roche, Risch-Rotkreuz, Switzerland) and 
oligonucleotides (Eurogentec) with amplicons detected using 
an FAM-labelled fluorescent probe (Eurogentec). Human 
RNaseP gene and GAPDH oligonucleotides (Eurogentec, 
Liège, Belgium) were used as internal amplification controls 
[23]. In total, 10µl aliquot of eluted nucleic acid was added to 
15 µl master mix in a 96-well reaction plate. The parameters 
using a real-time PCR LC480 analyser (Roche) were 95 °C 
for 5 mins, 45 cycles of 95 °C for 10 s, 60 °C for 45 s and 72 °C 
for 1 s and a final cooling step of 40 °C for 30 s. Based on the 
work of Bennett et al. a cycle threshold (Ct) of less than or 
equal to 38.7 was set as the cut-off for a positive result for the 
HSV-1 DNA amplification [8].
Laboratory study
Recovery of HSV-1 dnA from a CIM and a swab
Sterile CIM (Biopore filter paper, diameter 4 mm, pore size 
0.4 µm; Millicell-CM 0.4 µm PICM 01250, Millipore, Bedford, 
MA, USA) and swabs (Sigma) were used. A 4 mm diameter 
membrane was used based on previous work [17]. HSV-1 
virus stocks of 104, 103, 102 and 10 genome copies ml−1 were 
made by diluting cultured virus from a clinical isolate in buffer 
containing detergent (Hologic Apitima, Hologic, MA, USA). 
The number of virus genomes (copies ml−1) was determined 
using a commercial quantitative HSV-1/2 PCR kit (QIAGEN, 
Hilden, Germany). The assay was only used for this purpose 
and not testing CIM or swabs as currently only the presence 
or absence of HSV-1 DNA is clinically required. To mimic 
clinical samples, human genomic DNA (Roche Diagnostics, 
Burgess Hill, UK) was diluted 10 000-fold and 1 µl added to 
each CIM and swab. This dilution resulted in a Ct value of 29 
to 31, which was comparable to that obtained from a clinical 
sample.
Altogether, 5 µl of titrated HSV-1 cultured virus stock was 
applied to CIMs and allowed to soak into the material. Then, 
400 µl buffer containing detergent (Hologic) was added to 
one set of each duplicated sample and vortexed for 5 s before 
transfer of the liquid into a secondary tube for automated 
DNA extraction using the Roche MagNA Pure Compact and 
the Nucleic Acid Isolation Kit I DNA (Roche) with an elution 
volume of 50 µl. The CIM was left in the primary tube as it 
would have blocked the pipette tip on the extraction instru-
ment if transferred. The second set of each duplicant was 
stored at ambient temperature for 24 h before the addition of 
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400 µl buffer containing detergent and DNA extraction. For 
comparison, simulated corneal swabs were similarly inocu-
lated. Next, 5 µl HSV-1 at each dilution was applied to a swab, 
which was then added to a tube of 3 ml Sigma Virocult viral 
transport medium (MWE, Wiltshire, UK) and vortexed for 5 
s. A 400 µl aliquot of viral transport medium was transferred 
to a secondary tube before nucleic acid extraction as before. 
These extraction procedures were also used for the CIM and 
the swab in the clinical study below.
Topical anaesthetic is usually applied to the eye prior to collec-
tion of samples from the cornea and as such it was necessary 
to investigate a possible inhibitory effect on the PCR and 
HSV-1 recovery [24]. After adding 5 µl HSV-1 at 102 or 10 
virus copies ml−1 to each CIM, 1 µl of undiluted and diluted 
(1 in 102 and 103) proxymetacaine (Bausch and Lomb UK, 
Kingston-upon-Thamas, Surrey, UK) was added to each CIM 




Consecutive patients presenting to The Royal Liverpool 
University Hospital with suspected epithelial HSK were 
prospectively recruited between June 2016 and December 
2017. Patient demographics and clinical details including 
previous ophthalmic history, best-corrected visual acuity 
(BCVA), characteristics of lesions, extraocular manifestations 
and treatment, were collected using a standardized clinical 
form. Patients were categorized into probable, presumed 
and possible HSK by two independent observers. Probable 
HSK was defined as the presence of a dendritic or geographic 
ulcer with or without an associated corneal stromal keratitis. 
Presumed HSK was defined as an atypical keratitis (non-
dendritiform or non-geographic ulcers) with or without 
stromal lesions in a patient with a history of a previous 
and or recurrent HSK. Possible HSK was defined as clinical 
microbial keratitis in which HSV-1 was a consideration, but 
for which there were no typical HSK features and no history 
of HSK. Patients below age 18 years, with incomplete data 
either clinical or samples were excluded. All included patients 
provided informed consent. The study received Institutional 
Review Board approval from the ethical committee of The 
Royal Liverpool and Broadgreen University Hospital and was 
conducted according to the ethical standards set out in the 
1964 Declaration of Helsinki, as revised in 2000. There were 
no conflicts of interest.
Sample collection
Two samples (a corneal swab and a CIM) were collected from 
the corneal lesion at presentation. The order of collection was 
randomized. Following instillation of a topical anaesthetic 
(one drop of 0.5 % proxymetacaine) to the lower conjunctival 
fornix, a sample was collected. The swab was rolled across 
the corneal lesion and placed in 3 ml Sigma Virocult viral 
transport medium. This was followed or preceded by applica-
tion of a CIM (4 mm diameter millipore filter paper, pore size 
0.4 µm), to the surface of the lesion for 5 s using sterilized 
forceps. The filter paper was then transferred to a sterile tube 
without medium and transported dry to the laboratory for 
DNA extraction and PCR as described above using the Roche 
MagNA Pure Compact and the Nucleic Acid Isolation Kit 
I DNA (Roche). Corneal swabs were processed using the 
HSV-1 Dupuis primers as described above. CIM samples 
were processed using both the Ryncarz and Dupuis primers 
as described above.
Statistical methods
A sample size of 100 patients was based on alpha of 0.05, 
sensitivity 0.85, specificity 0.90, precision 0.1 and an assumed 
viral detection rate of 30–35 % with corneal swabs [25]. 
Statistical analysis was performed using SPSS (version 22). 
Independent t-tests were used to compare recovery of HSV-1 
DNA between CIMs extracted at 0 and 24 h and between the 
CIMs and swabs. Chi-square tests were used to compare the 
differences in HSV-1 detection rate between the CIM and 
conjunctival swab. One-way ANOVA was used to test for 
differences between the Dupuis and Ryncarz primer Ct values 
for the conjunctival swabs and CIMs. Post hoc analysis was 
carried out using the Bonferroni post hoc test.
RESuLTS
There was no evidence of inhibition of the HSV-1 PCR using 
CIM inoculated with 10 and 100 HSV-1 copies ml−1 in the 
presence or absence of different concentrations of eye drops 
(P=0.91, Table 1). DNA extracted immediately after HSV-1 
inoculation (wet) or 24 h after HSV-1 inoculation with dry 
storage yielded similar Ct values for both PCRs for all HSV-1 
dilutions (Fig.  1) (P=0.83). The Ct PCR values obtained 
following inoculation with a CIM were approximately three 
PCR cycles lower than the corresponding Ct values from a 
swab but this was not significant (P=0.18).
Clinical study
In total, 110 consecutive patients (56 males and 54 females) 
were included (mean age 55.4 years, sd±17.2). As determined 












10 None 35.7 31.3
10 Undiluted 35.7 31.5
10 1 : 100 34.9 31.6
10 1 : 1000 35.6 31.6
100 None 33.0 30.8
100 Undiluted 33.2 32.0
100 1 : 100 32.5 31.2
100 1 : 1000 32.5 32.0
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by two independent observers; 73 patients had probable, 20 
patients presumed and 17 patients possible HSV-1 keratitis. 
Overall, 45 patients (40.9 %) had a history of recurrent disease 
with previous episodes of HSK of whom 31 patients had 
pre-existing corneal scarring and 27 of these had associated 
corneal neovascularisation. Altogether, 58 patients (52.7 %) 
had BCVA of worse than 0.3 logMAR at presentation.
The HSV-1 detection rate using the Dupuis primers was 
significantly higher using a CIM (40/110, 36.4 %) than a 
swab (28/110, 25.5 %) (P=0.004) (Tables 2 and 3). Using the 
Dupuis primers, in the probable HSV keratitis group, the 
detection rate using a CIM was 43.8 % compared to 27.4 % 
for a swab (P=0.004). No significant difference was found 
between the HSV-1 detection rates between the CIM and the 
conjunctival swab in the presumed and possible HSK groups 
(Tables  2–4). The Ct values obtained for the conjunctival 
swabs were significantly higher than those obtained for the 
CIMs (P<0.001, Table 3).
There were no significant differences using a CIM between the 
Dupuis and Ryncarz primers for any of the three HSK groups 
(Table 4). There were three CIM samples out of 110, two from 
the probable and one from the presumed HSK group, where 
using the Dupuis primers, the PCR was borderline positive 
(35.5, 37.02 and 38.67 Ct) but negative using the Ryncarz 
primers. Of the swab samples from these three patients 
using the Dupuis primers, the CIM sample that gave a Ct of 
35.5 using the Dupuis primers also produced a positive swab 
result. The two further CIM samples (where the CIM was 
borderline positive at 37.02 and 38.67 Ct), however, gave a 
negative swab result. Two CIM samples from patients with 
probable HSK, were positive using the Ryncarz but not the 
Dupuis primers and the corresponding swabs were also posi-
tive using the Dupuis primers. Post hoc analysis, however, 
demonstrated no difference of the PCR Ct values between the 
two sets of HSV-1 primers (Table 4).
Fig. 1. Comparative sensitivities of HSV-1 PCRs using a CIM and a swab. Amplification of HSV-1 DNA from swabs and corneal impression 
membranes using Dupuis and Ryncarz primers. HSV-1 DNA was extracted immediately (0 h) and 24 h after inoculation. Ct values plotted 
for serial tenfold dilutions of virus genome copies ml−1. The amount of PCR amplicon increases at a rate of one log10 every 3.32 cycles 
under ideal conditions.
Table 2. HSV-1 detection rates using Dupuis real-time HSV-1 PCR
HSK n Swab positive 
(%)
CIM positive (%) P-value
Overall 110 28 (25.5) 40 (36.4) 0.004
Probable* 73 20 (27.4) 32 (43.8) 0.004
Presumed* 20 6 (30.0) 6 (30.0) 1
Possible* 17 2 (11.8) 2 (11.8) 1
CIM positive CIM negative Total
Swab positive 26 (65 %) 2 (2.9 %) 28
Swab negative 14 (35 %) 68 (97.1 %) 82
Total 40 70 110
*As determined by two independent observers.

















Overall 40 28.7 (4.3) 28 33.1 (4.2) <0.001
Probable* 32 29.1 (4.0) 20 33.1 (3.9) <0.001
Presumed* 6 27.8 (6.0) 6 33.3 (5.4) 0.037
Possible* 2 25.6 (1.5) 2 33.1 (6.6) 0.44
*As determined by two independent observers.
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dISCuSSIon
Microbial keratitis can be caused by a variety of micro-organ-
isms and accurate diagnosis with immediate treatment is 
important to optimize clinical outcome. Although the clinical 
features of HSK are important for the diagnosis, reliance on 
clinical features alone, may be misleading due to overlapping 
findings caused by different conditions and infections for 
example acanthamoeba and HSV-1, and excludes the ability 
to detect resistance mutations and or contact tracing.
Cell culture has been the traditional method for the detec-
tion of HSV-1, but has been largely replaced by PCR, due 
to its high sensitivity and shorter processing time. PCR has 
been optimized for the detection of HSV-1 from ophthalmic 
samples using swabs [8]. There is very little data, however, 
on the detection rates of HSV-1 from cases of HSK using 
swabs and although anecdotal, many ophthalmologists do not 
collect samples in cases of suspected HSV-1 keratitis possibly 
due to the low yield and cumbersome nature of a swab. It 
is also unclear whether in clinical practice the majority of 
specimens are collected from the conjunctiva and tear film 
rather than from the corneal ulcer itself. This carries the risk 
of detecting HSV-1 in cases of asymptomatic shedding into 
the conjunctival tear film [12, 13].
We compared two sets of HSV-1 primers as one had been 
used for the testing of cases of encephalitis and the other had 
been optimized for the testing of eye swabs but no clinical 
sample testing was reported [11]. Both showed good and 
comparable sensitivity. The CIM produced significantly 
higher results for patients with suspected HSK than a swab. 
Use of a CIM improves precision placement over the lesion 
and the membrane collects epithelial cells. This, in addition 
to the greater surface area, likely accounts for the increased 
detection rate observed in this study.
There were no significant differences in the detection rate 
between the two sets of primers, which would suggest that 
a specific set of primers is not peculiar to the technique. 
Despite the greater detection rate using a CIM compared 
to a swab, there were still up to 60 % where the result was 
negative. This would suggest that either the CIM is still not 
sensitive enough to detect HSV-1 DNA, or that the clinical 
diagnosis was incorrect or, that the stage of the disease was 
not associated with sufficient HSV-1 proliferation to be 
detected in the tear film. HSV-1 production has been shown 
to increase 4 days prior to clinical manifestation [26] and it 
is possible that the time to presentation was at a stage where 
the amount of virus present may be declining. As the use 
of a CIM is not invasive, it offers the opportunity to sample 
the cornea at repeated time points particularly if there is no 
response to treatment in those cases where there has been 
a negative result.
Somerville et al. [22] recently demonstrated the stability of 
HSV-1 DNA recovery following inoculation of HSV-1 onto 
PTFE CIMs and storage at +4, −20 and −70 °C for up to 
10 months using Dupuis primers. In this study, we obtained 
similar HSV-1 DNA Ct values to that demonstrated by 
Somerville et al., both from CIMs extracted immediately 
following sample collection and those extracted 24 h after 
collection and storage at +4 °C [22]. This suggests that there 
is no significant reduction in HSV-1 DNA recovery should 
there be a 24 h delay in sample processing. This is reflective 
of clinical settings, in which samples often do not reach the 
laboratory until the following day after the sample has been 
collected.
In clinical practice, because a topical anaesthetic is applied 
to the eye prior to a corneal sample (either a swab or a CIM) 
being collected, it was important therefore to demonstrate 
that there were no inhibitory effects on the PCR. Our in vitro 
data demonstrated good detection of HSV-1 DNA by PCR 
from CIM using both sets of primers with an end point of 
≤10 virus genome copies m−1, which would be suitable for 
testing clinical samples.
A CIM is easy to use and may therefore be suitable for 
use by non-ophthalmologists or where less sophisticated 
biomicroscopes are available, such as in resource-poor 
settings. The CIM has the potential to be produced as a 
medical product either individually or as part of a sampling 
device. In a recently published study, we compared the 
microbial detection rates of a corneal scrape to that using 
a CIM made from PTFE [17]. The results using a CIM 
were significantly better than using a blade to detect 
bacteria and acanthamoeba from corneal ulcers in cases of 
suspected microbial keratitis [17]. The results of this study 
would suggest that a CIM may additionally be a simple and 
good alternative to using sharp instruments and swabs for 
the identification of HSV-1 in cases of suspected micro-
bial keratitis. A CIM, therefore, offers the opportunity to 
investigate for bacterial, fungal, protozoan and viral causes 
in cases of suspected microbial keratitis, without the need 
for sharp instrumentation. Furthermore, a CIM has the 
potential to be used by non-ophthalmologists without 
specialized equipment.
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Overall 40 28.7 (4.3) 27.1 (3.9) 0.25
Probable* 32 29.1 (4.0) 27.6 (3.5) 0.37
Presumed* 6 27.8 (6.0) 23.7† (4.9) 0.73
Possible* 2 25.6 (1.5) 27.4 (6.2) 1
*As determined by two independent observers.
†Six CIM samples tested positive using the Dupuis primers and five 
samples tested positive using the Ryncarz primers.
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